Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy SPOC MIRACIP: … are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … 24 Feb 2025 - 5 May 2025 Conditions Academic Staff, Master students, PhD students, Researchers … SPOC MIRACIP: …Published on: